We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KR icon
4426
CALL
Kroger
KR
$34.6B
$989K ﹤0.01%
19,800
-51,300
-72% -$2.76M
SXT icon
4427
Sensient Technologies
SXT
$5.51B
$988K ﹤0.01%
13,313
-18,835
-59% -$1.38M
OR icon
4428
OR Royalties Inc
OR
$6.32B
$986K ﹤0.01%
63,317
-3,620
-5% -$58.6K
PMM
4429
Franklin Managed Municipal Income Trust
PMM
$272M
$986K ﹤0.01%
159,036
-25,893
-14% -$155K
RELX icon
4430
RELX
RELX
$62.1B
$986K ﹤0.01%
21,486
+3,762
+21% +$163K
ELAN icon
4431
PUT
Elanco Animal Health
ELAN
$11.1B
$984K ﹤0.01%
+68,200
New +$1.09M
JQC icon
4432
Nuveen Credit Strategies Income Fund
JQC
$712M
$982K ﹤0.01%
177,018
-64,670
-27% -$360K
REX icon
4433
REX American Resources
REX
$1.43B
$982K ﹤0.01%
43,078
-16,016
-27% -$427K
CRBP icon
4434
Corbus Pharmaceuticals
CRBP
$177M
$980K ﹤0.01%
21,649
+6,184
+40% +$260K
RPC
4435
Ridgepost Capital
RPC
$949M
$979K ﹤0.01%
115,479
+50,651
+78% +$404K
ENX
4436
DELISTED
Eaton Vance New York Municipal Bond Fund
ENX
$976K ﹤0.01%
99,027
-411
-0.4% -$3.97K
ADT icon
4437
ADT
ADT
$5.49B
$975K ﹤0.01%
128,350
-20,923
-14% -$145K
REYN icon
4438
Reynolds Consumer Products
REYN
$5.51B
$974K ﹤0.01%
34,809
-7,699
-18% -$219K
BATRA icon
4439
Atlanta Braves Holdings Series A
BATRA
$3.42B
$972K ﹤0.01%
23,527
-7,139
-23% -$296K
HLIO icon
4440
Helios Technologies
HLIO
$2.69B
$971K ﹤0.01%
20,336
-25,825
-56% -$1.24M
GPRE icon
4441
Green Plains
GPRE
$1.06B
$969K ﹤0.01%
61,122
-51,229
-46% -$987K
AGX icon
4442
Argan
AGX
$8.15B
$969K ﹤0.01%
13,248
-4,615
-26% -$302K
BKAG icon
4443
BNY Mellon Core Bond ETF
BKAG
$2.23B
$968K ﹤0.01%
23,370
-922
-4% -$38K
DAWN
4444
DELISTED
Day One Biopharmaceuticals
DAWN
$966K ﹤0.01%
70,083
-93,935
-57% -$1.37M
PAR icon
4445
PAR Technology
PAR
$751M
$965K ﹤0.01%
20,495
-16,607
-45% -$734K
CRMT icon
4446
America's Car Mart
CRMT
$26.1M
$964K ﹤0.01%
16,006
-6,298
-28% -$380K
TEF
4447
DELISTED
Telefonica
TEF
$962K ﹤0.01%
228,420
+115,151
+102% +$509K
AFB
4448
AllianceBernstein National Municipal Income Fund
AFB
$316M
$960K ﹤0.01%
86,451
-17,121
-17% -$184K
GNOM icon
4449
Global X Genomics & Biotechnology ETF
GNOM
$87.5M
$960K ﹤0.01%
23,000
-811
-3% -$33.9K
CHEF icon
4450
Chefs' Warehouse
CHEF
$4.44B
$958K ﹤0.01%
24,497
-19,542
-44% -$722K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.